ArticleCureus2025
Hematological Characteristics of Patients With Sickle Cell Disease in Al Ahsa, Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multidimensional Predictors of Disease Severity and Health Outcomes in Patients with Sickle Cell Disease:Saudi medical journal · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease (SCD) is an autosomal recessive illness characterized by severe morbidity and mortality rates. Although numerous studies on SCD have been conducted worldwide, the hematological features of SCD in the Middle East require further investigation. Therefore, we conducted this study to examine the hematological characteristics of SCD in Saudi Arabia, specifically in the Al Ahsa region. We performed a retrospective examination of health records at King Fahad Hospital in Hofuf, and data were analyzed in relation to gender, age, and other demographic factors. This study included a total of 96 records, with an average age of patients being 33 years. The majority of the patients (60%) were male. Most of the patients were anemic (99%), with one-quarter (26%) suffering from mild-to-moderate anemia (hemoglobin (Hb) above 10 g/dL) and the remaining three-quarters (74%) suffering from severe anemia (Hb below 10 g/dL). Correlation studies show that older patients (above 50 years old) are more severely affected by the disease compared to younger adult groups, evidenced by a strong negative correlation between age and both Hb levels and red blood cell counts (RBCs). Severe anemia is more common in females than in males, with a mean Hb of 8.4 g/dL in females (79% having Hb below 10 g/dL) compared to a mean Hb of 9.0 g/dL in males (71% having Hb below 10 g/dL). About half of the studied SCD population showed abnormal platelet counts (51%), with no significant difference between males and females. Thrombocytosis was slightly more prevalent than thrombocytopenia (31% vs. 20%). Our study indicates that SCD in Al Ahsa, Saudi Arabia, is associated with moderate-to-severe anemia. The impact of the disease is more pronounced in older individuals and females. Abnormal platelet counts are common among SCD patients in the Al Ahsa region. These findings should be taken into account when addressing SCD in the eastern province of Saudi Arabia and possibly in other regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.